	Construction of a liver hepatocellular carcinoma risk model based on fumarate metabolism-associated genes to predict prognosis and immunological landscape. Clin Exp Med Chen S, Xie S, Mei Y, Yu H, Yan J. PMID: 42900287 [PubMed - indexed for MEDLINE]
	Distinct immune signatures define hepatitis D- versus hepatitis B-associated hepatocellular carcinoma. Hepatol Commun Glimmann S, Deterding K, Bock K, Bremer B, Kraft ARM, Cornberg M, Wedemeyer H, Heinrich B, Wranke A. PMID: 42900159 [PubMed - indexed for MEDLINE]
	Similar Long-Term Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Initiating Entecavir Versus Tenofovir Alafenamide: A REAL-B Study. J Viral Hepat Uojima H, Huang R, Trinh H, Nozaki A, Vutien P, Toyoda H, Honda T, Abe H, Atsukawa M, Watanabe T, Ishikawa T, Enomoto M, Tanaka Y, Takaguchi K, Tsai PC, Chuang WL, Dai CY, Huang JF, Huang CF, Yeh ML, Senoh T, Maeda M, Cheung R, Ito T, Morimoto M, Yu ML, Wu C, Nguyen MH. PMID: 42897886 [PubMed - indexed for MEDLINE]
	Interaction between microvascular invasion and early recurrence of hepatocellular carcinoma in cirrhosis patients with curative liver resection: a retrospective cohort study. BMC Gastroenterol Qiang Y, Duan B. PMID: 42897494 [PubMed - indexed for MEDLINE]
	Characterizing the spatiotemporal displacement of fiducial markers for cyberknife radiosurgery in liver cancer and identifying predictive factors. BMC Cancer Zhang M, Nie L, Zhao D, Xu H, Zhang G, Tian B. PMID: 42894144 [PubMed - indexed for MEDLINE]
	Multifactorial Contributors to Diagnostic Delay in a High-Risk Patient with Hepatocellular Carcinoma: A Case Report with Clinical Lessons. Int Med Case Rep J Hu J, Guo L, Chen T, Zhang J, Jiang Q. PMID: 42893132 [PubMed - indexed for MEDLINE]
	Surgical resection versus stereotactic body radiotherapy for oligometastatic breast cancer to the liver. Clin Exp Metastasis Niu L, Zhu L, Zhang Q, Bai Y, Fang Q, Sun X, Guo W. PMID: 42891744 [PubMed - indexed for MEDLINE]
	From cold to hot: the immunomodulatory framework of Saikosaponin D in hepatocellular carcinoma therapy. Front Immunol Huang X, Liu L, Qin M, Liu R. PMID: 42889783 [PubMed - indexed for MEDLINE]
	TACE-HAIC combined with apatinib and camrelizumab for unresectable hepatocellular carcinoma with portal vein tumor thrombus: a multicenter retrospective study. Front Immunol Zhang X, Shi S, Su Y, Ma Y, Guo Q, Meng X, Wang R, Long J, Yang J, Xiong B. PMID: 42889344 [PubMed - indexed for MEDLINE]
	Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinoma. Medicine (Baltimore) Xu G, Zhang J, Li X, Fan S, Wu X, Zhou C. PMID: 42888556 [PubMed - indexed for MEDLINE]
	Three traditional Chinese patent medicines combined with transarterial chemoembolization for primary liver cancer: A systematic review and Bayesian network meta-analysis. Medicine (Baltimore) Jiang W, Luo J, Wu C, An Y, Dai Y, Shi J, Lan C, Qi J, Hua S, Liu H. PMID: 42888555 [PubMed - indexed for MEDLINE]
	Histopathologic spectrum of focal liver lesions diagnosed by ultrasound-guided percutaneous liver biopsy and predictors of hepatocellular carcinoma: A single-center experience from Sub-Saharan Africa. PLoS One Elias TP, Shewaye AB, Berhane KA, Mohammed A, Tibebu Z, Gebreselassie AG, Abie AS. PMID: 42886641 [PubMed - indexed for MEDLINE]
	Erythema Multiforme after Liver Transplant: A Rare Pediatric Case Report. Exp Clin Transplant Nacakgedi, Tirali RE, Belen Apak B, I, K, Araz K, Haberal M. PMID: 42885709 [PubMed - indexed for MEDLINE]
	Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma. Nutrients Adachi Y, Shimada S, Mizukami S, Takizawa T, Enomoto K, Makino K, Takahata H, Takahashi H, Imai K, Yokoo H. PMID: 42884598 [PubMed - indexed for MEDLINE]
	Corosolic Acid in Hepatocellular Carcinoma: Molecular Properties, Evidence Boundaries, and Development Priorities. Molecules Zhu S, Chen B, Qu J, Wang W, Zhang Z. PMID: 42883239 [PubMed - indexed for MEDLINE]
	Clinically Significant Portal Hypertension in Hepatocellular Carcinoma: Non-Invasive Assessment Across the Continuum. Curr Oncol Rep Ji P, Luo W, Cheng L, Xu Z. PMID: 42881321 [PubMed - indexed for MEDLINE]
	Cell-free DNA methylation markers in the diagnosis of hepatitis B virus-related- hepatocellular carcinoma: a review. Mol Biol Rep Soubeiga ST, Ouattara AK, Ilboudo C, Djigma WF, Simpore J. PMID: 42878936 [PubMed - indexed for MEDLINE]
	Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC. Hepatol Commun Sun J, Lu Y, Chang L, Gao R, Guan M, Ruan H, Deng X. PMID: 42878587 [PubMed - indexed for MEDLINE]
	Impact of body composition on clinical outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis. Hepatol Commun Pinto E, Barberio B, Gambato M, Ferdinande K, Marchese E, Ferrarese A, Germani G, Senzolo M, Russo FP, Burra P, Zanetto A. PMID: 42878582 [PubMed - indexed for MEDLINE]
	Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of 78 Studies and 68,243 Patients. J Viral Hepat Kudaravalli S, Yan T, Tseng CH, Hsu YC, Li X, Wu Y, Chen B, Gao X, Gao S, Ren D, Qian X, Sands W, Cheung R, Nguyen MH. PMID: 42876044 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77857

Page 1 of 3893



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy